RAZUMAB 2.3MG INJECTION 0.23 ML

How RAZUMAB 2.3MG INJECTION 0.23 ML Works

• RAZUMAB 2.3MG INJECTION 0.23 ML is a targeted therapy medication classified as a monoclonal antibody. In the context of cancer treatment, RAZUMAB 2.3MG INJECTION 0.23 ML functions by inhibiting angiogenesis, which is the formation of new blood vessels. Tumors require a blood supply to grow and spread; these blood vessels provide the necessary oxygen and nutrients for cancer cells to proliferate.
• By blocking the vascular endothelial growth factor (VEGF), a protein that stimulates angiogenesis, RAZUMAB 2.3MG INJECTION 0.23 ML effectively cuts off the tumor's lifeline. This deprives the cancerous cells of the resources they need to survive and multiply, leading to a slowdown in the tumor's growth rate.
• Furthermore, inhibiting angiogenesis can hinder the spread of cancer cells to other parts of the body (metastasis). The overall effect of RAZUMAB 2.3MG INJECTION 0.23 ML is to impede the progression of the disease by targeting a crucial mechanism that fuels tumor development and spread. It's generally used in combination with other treatments like chemotherapy.

Most side effects are temporary and disappear as your body gets used to the medicine. However, if they continue or worsen, please consult your doctor.

• Conjunctival hemorrhage
• Eye pain
• Increased intraocular pressure
• Foreign body sensation in eyes
• Blurred vision
• Nausea
• Dry eye
• Eye itching
• Cataract
• Vitreous floaters
• Vitreous detachment
• Intraocular inflammation
• Eye irritation
• Increased lacrimation
• Eyelid inflammation
• Ocular hyperemia
• Retinal disorder
• Maculopathy
• Eye discomfort
• Posterior capsule opacification
• Injection site hemorrhage
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Anemia (low number of red blood cells)
• Joint pain
• Renal failure
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Gastro-esophageal reflux disease
• Hypercholesterolemia (high cholesterol)
• Bronchitis (inflammation of the airways)

• Keep RAZUMAB 2.3MG INJ 0.23ML away from the reach of children and pets.
• Store RAZUMAB 2.3MG INJ 0.23ML in a refrigerator (2 - 8°C). Do not freeze.

• After receiving RAZUMAB 2.3MG INJECTION 0.23 ML, you might experience temporary visual disturbances. It's crucial to avoid driving or operating machinery until you are confident that your vision is clear and unaffected. This usually takes a few hours, but it can vary.
• If you notice any increased eye pain or redness, new or worsening blurred vision, a sudden decrease in vision, or increased sensitivity to light after the injection, promptly inform your doctor. These symptoms could indicate a potential complication that requires immediate attention.
• Your eyes may be more sensitive to light after the injection. Wearing sunglasses, especially outdoors, can help to reduce discomfort and protect your eyes from bright light.
• If your doctor prescribes eye drops, use them as directed to help soothe your eyes and prevent infection. Follow the dosage and frequency instructions carefully.
• Consult your doctor about any activities you should avoid after the injection. Strenuous activities or those that put strain on your eyes might be discouraged for a short period.
• Resting your eyes as much as possible in the initial hours following the injection is recommended. This helps to reduce eye strain and promote healing. Avoid prolonged screen time or reading during this period.
• Remember that individual responses to RAZUMAB 2.3MG INJECTION 0.23 ML can vary. Always follow your doctor's specific instructions and attend all scheduled follow-up appointments for monitoring and care.